Simplex Trading’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $60.2K | Buy |
15,600
+11,500
| +280% | +$45.3K | ﹤0.01% | 5664 |
|
|
2025
Q4 | $16.1K | Sell |
4,100
-85,300
| -95% | -$377K | ﹤0.01% | 6662 |
|
|
2025
Q3 | $417K | Buy |
89,400
+85,500
| +2,192% | +$309K | ﹤0.01% | 4059 |
|
|
2025
Q2 | $12K | Sell |
3,900
-1,900
| -33% | -$6.13K | ﹤0.01% | 7207 |
|
|
2025
Q1 | $19K | Buy |
5,800
+1,100
| +23% | +$5.14K | ﹤0.01% | 6634 |
|
|
2024
Q4 | $26K | Buy |
4,700
+2,700
| +135% | +$17.4K | ﹤0.01% | 6484 |
|
|
2024
Q3 | $11K | Sell |
2,000
-26,700
| -93% | -$194K | ﹤0.01% | 7156 |
|
|
2024
Q2 | $227K | Buy |
28,700
+25,300
| +744% | +$212K | ﹤0.01% | 4544 |
|
|
2024
Q1 | $31K | Buy |
3,400
+2,200
| +183% | +$18.6K | ﹤0.01% | 6732 |
|
|
2023
Q4 | $10K | Sell |
1,200
-500
| -29% | -$3.63K | ﹤0.01% | 7467 |
|
|
2023
Q3 | $13K | Sell |
1,700
-30,200
| -95% | -$276K | ﹤0.01% | 7012 |
|
|
2023
Q2 | $365K | Buy |
31,900
+2,200
| +7% | +$22.8K | ﹤0.01% | 3634 |
|
|
2023
Q1 | $228K | Buy |
29,700
+6,600
| +29% | +$52.5K | ﹤0.01% | 4176 |
|
|
2022
Q4 | $140K | Sell |
23,100
-155,800
| -87% | -$885K | ﹤0.01% | 4672 |
|
|
2022
Q3 | $1.06M | Buy |
178,900
+12,700
| +8% | +$81.3K | ﹤0.01% | 2578 |
|
|
2022
Q2 | $982K | Buy |
166,200
+63,600
| +62% | +$430K | ﹤0.01% | 2644 |
|
|
2022
Q1 | $781K | Buy |
102,600
+56,600
| +123% | +$252K | ﹤0.01% | 3234 |
|
|
2021
Q4 | $124K | Buy |
46,000
+37,200
| +423% | +$127K | ﹤0.01% | 5919 |
|
|
2021
Q3 | $35K | Hold |
8,800
| – | – | ﹤0.01% | 7961 |
|
|
2021
Q2 | $36K | Buy |
8,800
+8,750
| +17,500% | +$39.7K | ﹤0.01% | 8053 |
|
|
2021
Q1 | $23K | Buy |
50
+19
| +61% | +$130 | ﹤0.01% | 7359 |
|
|
2020
Q4 | $22K | Buy |
31
+20
| +182% | +$192 | ﹤0.01% | 6923 |
|
|
2020
Q3 | $11K | Sell |
11
-23
| -68% | -$270 | ﹤0.01% | 6758 |
|
|
2020
Q2 | $42K | Sell |
34
-1
| -3% | -$12 | ﹤0.01% | 5649 |
|
|
2020
Q1 | $32K | Sell |
35
-117
| -77% | -$1.34K | ﹤0.01% | 5572 |
|
|
2019
Q4 | $212K | Sell |
152
-57
| -27% | -$829 | ﹤0.01% | 3691 |
|
|
2019
Q3 | $359K | Buy |
209
+158
| +310% | +$3.32K | ﹤0.01% | 2974 |
|
|
2019
Q2 | $138K | Buy |
51
+48
| +1,600% | +$1.1K | ﹤0.01% | 3866 |
|
|
2019
Q1 | $5K | Sell |
3
-3
| -50% | -$39 | ﹤0.01% | 6494 |
|
|
2018
Q4 | $5K | Sell |
6
-8
| -57% | -$103 | ﹤0.01% | 6241 |
|
|
2018
Q3 | $26K | Sell |
14
-9
| -39% | -$173 | ﹤0.01% | 5759 |
|
|
2018
Q2 | $44K | Sell |
23
-13
| -36% | -$257 | ﹤0.01% | 5189 |
|
|
2018
Q1 | $10K | Buy |
+36
| New | +$778 | ﹤0.01% | 4063 |
|
|
2017
Q4 | – | Sell |
-45
| Closed | -$8K | – | 6774 |
|
|
2017
Q3 | $8K | Buy |
+45
| New | +$508 | ﹤0.01% | 4018 |
|
Other funds holding VYGR
AC
VPC
VCM
OM
EAM
Simplex Trading's VYGR Position: Q1 2026 in Review
Simplex Trading increased its Voyager Therapeutics (VYGR) stake by 174% in Q1 2026, buying an estimated $55.6K and bringing the position to 22,261 shares worth $85.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5271.
Simplex Trading first reported a position in VYGR in Q3 2017 and has held it in 25 quarters since. The position peaked at $650K in Q2 2019. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.
- Simplex Trading held 22,261 shares of Voyager Therapeutics worth $85.9K as of Q1 2026.
- Simplex Trading bought 14,126 Voyager Therapeutics shares in Q1 2026, an estimated $55.6K.
- Voyager Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5271 holding.
- Simplex Trading first reported a position in Voyager Therapeutics in Q3 2017 and has held it in 25 quarters since.
- Simplex Trading's Voyager Therapeutics position peaked at $650K in Q2 2019.
- 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.